RNA viruses as virotherapy agents

Russell SJ . Replicating vectors for gene therapy of cancer: risks, limitations and prospects Eur J Cancer 1994 8: 1165–1171

Russell SJ . Replicating vectors for cancer therapy: a question of strategy Semin Cancer Biol 1994 5: 437–443

Asada T . Treatment of human cancer with mumps virus Cancer 1974 34: 1907–1928

Lamb R, Kolakofsky D . Paramyxoviridae: the viruses and their replication In: Knipe D, Howley P, eds Fields' Virology Philadelphia: Lippincott, Williams and Wilkins 2001 1305–1340

Shimizu Y, Hasumi K, Okudaira Y et al. Immunotherapy of advanced gynecologic cancer: patients utilizing mumps virus Cancer Detect Prev 1988 12: 487–495

Beard CW, Hanson RP . Newcastle disease In: Hofstad MS, ed Disease of Poultry 8th ed Ames: Iowa State University Press 1984 452–470

Reichard KW, Lorence RM, Cascino CJ et al. Newcastle disease virus selectively kills human tumor cells J Surg Res 1992 52: 448–453

Phuangsab A, Lorence RM, Reichard KW et al. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration Cancer Lett 2001 172: 27–36

Lorence RM, Katubig BB, Reichard KW et al. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy Cancer Res 1994 54: 6017–6021

Lorence RM, Reichard KW, Katubig BB et al. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy J Natl Cancer Inst 1994 86: 1228–1233

Nagai Y . Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding Rev Med Virol 1999 9: 83–99

Pecora AL, Rizvi N, Cohen GI et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers J Clin Oncol 2002 20: 2251–2266

Griffin D . Measles virus In: Knipe DM, Howley PM, eds Fields' Virology 4th edition Philadelphia: Lippincott, Williams and Wilkins 2001 Vol. 1: 1401–1441

Bluming AZ, Ziegler JL . Regression of Burkitt's lymphoma in association with measles infection Lancet 1971 105–106

Grote D, Russell SJ, Cornu TI et al. Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice Blood 2001 97: 3746–3754

Peng K-W, TenEyck C, Galanis E et al. Intraperitoneal therapy of ovarian cancer using an engineered measles virus Cancer Res 2002 62: 4656–4662

Peng KW, Ahmann GJ, Pham L et al. Systemic therapy of myeloma xenografts by an attenuated measles virus Blood 2001 98: 2002–2007

Peng KW, Facteau S, Wegman T et al. Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides Nat Med 2002 8: 527–531

Ono N, Tatsuo H, Hidaka Y et al. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor J Virol 2001 75: 4399–4401

Jurianz K, Ziegler S, Garcia-Schuler H et al. Complement resistance of tumor cells: basal and induced mechanisms Mol Immunol 1999 36: 929–939

Erlenhofer C, Duprex WP, Rima BK et al. Analysis of receptor (CD46, CD150) usage by measles virus J Gen Virol 2002 83: 1431–1436

Esolen LM, Park SW, Hardwick JM et al. Apoptosis as a cause of death in measles virus–infected cells J Virol 1995 69: 3955–3958

Radecke F, Spielhofer P, Schneider H et al. Rescue of measles viruses from cloned DNA EMBO J 1995 14: 5773–5784

Hammond AL, Plemper RK, Zhang J et al. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen J Virol 2001 75: 2087–2096

Peng K, Donovan K, Schneider U et al. Oncolytic measles viruses displaying a single chain antibody against CD38, a myeloma cell marker submitted for publication

Schneider U, Bullough F, Vongpunsawad S et al. Recombinant measles viruses efficiently entering cells through targeted receptors J Virol 2000 74: 9928–9936

Rose JK, Whitt MA . Rhabdoviridae: the viruses and their replication In: Knipe DM, Howley PM, eds Fields' Virology 4th edition Philadelphia: Lippincott, Williams and Wilkins 2001 Vol. 1: 1221–1244

Belkowski LS, Sen GC . Inhibition of vesicular stomatitis viral mRNA synthesis by interferons J Virol 1987 61: 653–660

Stojdl DF, Lichty B, Knowles S et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus Nat Med 2000 6: 821–825

Balachandran S, Porosnicu M, Barber GN . Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis J Virol 2001 75: 3474–3479

Stojdl DF, Abraham N, Knowles S et al. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus J Virol 2000 74: 9580–9585

DePolo NJ, Reed JD, Sheridan PL et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum Mol Ther 2000 2: 218–222

Fernandez M, Porosnicu M, Markovic D et al. Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease J Virol 2002 76: 895–904

Tyler KL, Fields BN . Mammalian reoviruses In: Fields BN, Knipe DM, Howley PM, eds Fields' Virology Philadelphia: Lippincott-Raven 1996 1597–1623

Mundschau LJ, Faller DV . Endogenous inhibitors of the dsRNA-dependent eIF-2 alpha protein kinase PKR in normal and ras-transformed cells Biochimie 1994 76: 792–800

Strong JE, Coffey MC, Tang D et al. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus EMBO J 1998 17: 3351–3362

Coffey MC, Strong JE, Forsyth PA et al. Reovirus therapy of tumors with activated Ras pathway Science 1998 282: 1332–1334

Hirasawa K, Nishikawa SG, Norman KL et al. Oncolytic reovirus against ovarian and colon cancer Cancer Res 2002 62: 1696–1701

Norman KL, Coffey MC, Hirasawa K et al. Reovirus oncolysis of human breast cancer Hum Gene Ther 2002 13: 641–652

Wilcox ME, Yang W, Senger D et al. Reovirus as an oncolytic agent against experimental human malignant gliomas J Natl Cancer Inst 2001 93: 903–912

Roner MR . Rescue systems for dsRNA viruses of higher organisms Adv Virus Res 1999 53: 355–367

Dock G . Influence of complicating diseases upon leukaemia Am J Med Sci 1904 127: 563–592

Bergmann M, Romirer I, Sachet M et al. A genetically engineered influenza A virus with ras-dependent oncolytic properties Cancer Res 2001 61: 8188–8193

Neumann G, Kawaoka Y . Reverse genetics of influenza virus Virology 2001 287: 243–250

Hatada E, Saito S, Fukuda R . Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells J Virol 1999 73: 2425–2433

Racaniello VR . Picornaviridae: the viruses and their replication In: Knipe DM, Howley PM, eds Fields' Virology 4th edition Philadelphia: Lippincott, Williams and Wilkins 2001 Vol. 1: 685–722

Evans DJ . Reverse genetics of picornaviruses Adv Virus Res 1999 53: 209–228

Gromeier M, Lachmann S, Rosenfeld MR et al. Intergeneric poliovirus recombinants for the treatment of malignant glioma Proc Natl Acad Sci USA 2000 97: 6803–6808